Ozempic drought continues

Healthed

writer

Healthed

Healthed

Worldwide shortages cause to TGA put the brakes on prescribing

Ozempic supply will be limited for the rest of this year and throughout 2024, as demand has accelerated in recent months, the Therapeutic Goods Administration announced last week.

After consultation with the Ozempic Medicine Shortage Action Group, the TGA is advising prescribers:

  • Not to initiate new patients on Ozempic unless there are no suitable alternatives or there is a compelling clinical reason to do so.
  • Consider if patients already prescribed Ozempic can be changed to
    an alternative as continuous supply cannot be guaranteed
  • Conserve supplies for patients who are stabilised on Ozempic who have no other treatment options

“When deciding whether to continue treatment consult the appropriate prescribing guidelines. Prioritise patients for whom Ozempic will have the most clinical impact, including patients already stabilised on the medicine and without other treatment options,” the TGA advised.

Ozempic’s TGA-approved indication is for the management of type 2 diabetes not adequately managed by other medications, in conjunction with diet and exercise.

Manufacturer Novo Nordisk said that very limited new supplies of Ozempic 0.25/0.5 mg will be available before the end of 2023 and supply of all strengths of Ozempic will be intermittent for the rest of 2023 and throughout 2024.

Ozempic is in shortage worldwide and the issue is not limited to Australia.

Novo Nordisk has said they are increasing manufacturing capacity, but is not known when the medicine will be available in sufficient quantities to meet the ongoing high demand.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Deborah Bateson AM

Prof Deborah Bateson AM

The Natural Estrogen Debate: A Focus on Combined Oral Contraception

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm

Panel Discussion on GLP1s for Chronic Kidney Disease in Type 2 Diabetes

Dr Gabby Mahoney

Dr Gabby Mahoney

Eczema Management Practical Tips

Prof Rodney Baber AM

Prof Rodney Baber AM

Menopausal Hormone Therapy and its Cardiovascular Benefits

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Healthed

writer

Healthed

Test your knowledge

Recent articles

Latest GP poll

The government's bulk billing incentives start on 1 November. How accurate do you think the government's messaging to the public has been?

Very misleading

0%

Moderately misleading

0%

Slightly misleading

0%

Not at all misleading

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Eczema management practical tips

Tuesday 28th October, 7pm - 9pm AEDT

Speaker

Dr Gabby Mahoney

Paediatric Allergist and Immunologist; Royal Children's Hospital

We invite you to our next free webcast, where Dr Gabby Mahoney will present on eczema management ractical tips. Up to 4 hours CPD. RACGP & ACRRM accredited.